Navigation Links
Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs

NEW YORK, Sept. 17 /PRNewswire/ -- ExL Pharma is pleased to announce three Clinical Data Focused conferences which cover many of the leading issues that are impacting the pharmaceutical industry today. These events offer educational and networking opportunities for Clinical, R&D, Regulatory and Medical Affairs executives from large to small pharmaceutical, biotech, device and medical technology companies.

Listed below are details on some of the featured events and highlights from those conferences:

October 15-16, San Francisco, CA

2nd Data Monitoring Committees/DSMBs Conference -- Evaluating Trial Safety

and Efficacy through Independent Examination of Interim Clinical Data

Following a successful inaugural DMC conference in February of 2007, where over 100 industry experts gathered in Philly, ExL Pharma is proud to announce the 2nd DMC conference taking place October 15-16 in San Francisco where the industry will once again gather to evaluate trial safety and efficacy through independent examination of interim clinical data. Hear case study examples from GSK, AstraZeneca, Genentech, Amgen and join the industry's leading authorities on Drug Safety, Regulatory Affairs and Biostatistics to discuss experiences, strategies and best practices for working with DMCs and incorporating them into clinical trial designs to mitigate risk, optimize resource allocation, reassure study integrity and increase safety.

November 5-6, Arlington, VA

Pediatric Clinical Trials Conference -- Increasing Efficiency in Drug

Development by Redefining Global Regulation and Identifying Trial


Featuring roundtable discussions chaired by Dean Steven Spielberg from Dartmouth Medical School; topics lead by experts in each field include CNS/Psychiatry, Infectious Disease, Oncology, Gastroenterology, and Geographic Study Differences. Other event presentations include NICHD perspective on Best Pharmaceuticals for Children Act, changes in pediatric regulatory landscape, and industry sponsored research.

December 3-4 2007, Philadelphia, PA

Pharmacovigilance Summit 2007 -- Developing and Implementing Compliant

Strategies to Minimize the Risk of Adverse Drug Reactions and Increase

Drug Safety

The only conference focusing on developing and implementing compliant strategies to minimize the risk of adverse drug reactions and increase drug safety. AstraZeneca, Cephalon Inc, Intermune, Sunesis Pharmaceuticals and more discuss practical crisis management and communications strategies, measuring the effectiveness of your pharmacovigilance efforts, and evaluating the effectiveness of your risk management plans and tools and more. Pre-conference workshop on The Impact of Regulation on Drug Safety.

To view our full list of upcoming conferences and webinars and details on our expert speaking faculties or to REGISTER, Log onto:

*Please mention Registration Code: ECL913 when registering

About ExL

ExL Pharma, a division of ExL Events, Inc., is an emerging leader in developing innovative, educational events that serve the healthcare community and allied professionals. Behind our diverse conference portfolio, our experienced team conducts extensive market research and targeted outreach. The results translate into innovative, high-quality conference events designed to exceed the dynamic informational needs of the healthcare community.

Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Pharma majors gear to supply anti-anthrax drug
2. First Artificial Heart patient has Major setback
3. Allergies: A major health problem
4. Animal insulin product to be discontinued by drug major Eli Lilly
5. Vision Loss Due To Diabetic Retinopathy a Major Cause Of Concern
6. Depression Found To Be A Major Cause for Death in Elderly
7. Genetics Has A Major Role To Play In Body Shape.
8. “Yes, I need Cosmetic surgery” – view of majority wome
9. Pigs Population A Major Threat To Encephalitis Ravaged UP
10. Unsafe Injections and Unclean Hand hygiene major cause of hospital infections in India
11. Delhi Government To Interlink All Major Hospitals Through e-Governance
Post Your Comments:
(Date:10/13/2017)... ... October 13, 2017 , ... Global Healthcare Management’s 4th ... Park in Milford, NJ. This free event, sponsored by Global Healthcare Management’s CEO, ... The fun run is geared towards children of all ages; it is a non-competitive, ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, ... Development, has been awarded a contract by the Center for Medicare and Medicaid ... to accelerate the enterprise use of Agile methodologies in a consistent and high ...
(Date:10/12/2017)... WILMINGTON, Del. (PRWEB) , ... October 12, 2017 ... ... technology and advisory services for healthcare compliance program management, will showcase a range ... and National Association for Assisted Living (NCAL) Convention and Expo to be held ...
(Date:10/12/2017)... Wis. (PRWEB) , ... October 12, 2017 , ... ... standard products to meet the demand of today’s consumer and regulatory authorities worldwide. ... of probiotic experts and tested to meet the highest standard. , These ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... leader in post-acute health care, have expanded their existing home health joint venture ... , AccentCare has been operating a joint venture home health company with Asante, ...
Breaking Medicine News(10 mins):
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, Inc. ... response letter from the U.S. Food and Drug Administration ... of sirukumab for the treatment of moderately to severely ... additional clinical data are needed to further evaluate the ... severely active RA. ...
(Date:9/19/2017)... HistoSonics, Inc., a venture-backed medical device company developing a non-invasive, robotically assisted, platform therapy that ... developments today:   ... ... Tom Tefft ... Veteran medical device executive Josh Stopek , PhD, who has led R&D and ...
(Date:9/18/2017)... R.I. , Sept. 18, 2017 /PRNewswire/ ... the fields of bioinformatics and immune engineering, ... a protective avian influenza A (H7N9) vaccine. ... distantly related to seasonal influenza and presents ... rely on prior exposure to be effective. ...
Breaking Medicine Technology: